TetraLogic Pharmaceuticals Corporation
OTC: TLOG0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yigong Shi
- Employees
- 29
- Headquarters
- Malvern, United States
- IPO year
- 2013
- Market cap
- $979.0
- Website
- https://www.tetralogicpharma.com
Loading TLOG…
Loading profile data…Frequently asked questions about TLOG
What does TetraLogic Pharmaceuticals Corporation (TLOG) do?
TetraLogic Pharmaceuticals Corporation operates as a clinical-stage biopharmaceutical firm, concentrating its efforts on identifying and advancing small-molecule treatments for cancer and infectious diseases. The company's development pipeline features two key clinical-stage drug candidates: birinapant and SHAPE. Birinapant, a small molecule, fu...
Where does TLOG trade?
TetraLogic Pharmaceuticals Corporation (TLOG) trades on the Other OTC.
What sector is TLOG in?
TetraLogic Pharmaceuticals Corporation (TLOG) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of TetraLogic Pharmaceuticals Corporation?
Yigong Shi is the chief executive officer of TetraLogic Pharmaceuticals Corporation (TLOG).
Where is TetraLogic Pharmaceuticals Corporation headquartered?
TetraLogic Pharmaceuticals Corporation is headquartered in United States.
Does TLOG pay a dividend?
TetraLogic Pharmaceuticals Corporation (TLOG) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TLOG go public?
TetraLogic Pharmaceuticals Corporation (TLOG) completed its initial public offering in 2013.